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Literature indicated that platelets could be used as a model for neuronal receptors such as γ- 
amino butyric acid (GABA) and serotonin. Research work exhibited the presence of low levels of 
GABA and high levels of serotonin concentration in the platelets of autistic children as compare to 
their healthy counter parts. There are also other evidences pointing out to the significant role of 
GABA in autism such as association of g-band frequency with the cortical concentration of GABA 
and gabapentin (GABA analogue) specifically inhibits the cytosolic branched chain amino transfe-
rase (BCATc); an enzyme responsible to modulate glutamate availability for the synthesis of GABA. 
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It was previously suggested that platelets could be used as a model for neuronal receptors such as amino butyric 
acid (GABA) and serotonin [1] [2]. Our work in progress and literature [3], revealed the presence of low levels 
of GABA and high levels of serotonin concentration in the platelets of autistic children as compare to their age 
matched healthy counter parts. There are also other evidences pointing out to the significant role of GABA in 
autism such as association of g-band frequency with the cortical concentration of GABA [4] and gabapentin 
(GABA analogue) specifically inhibit cytosolic branched chain amino transferase (BCATc); an enzyme respon-
sible to modulate glutamate availability for the synthesis of GABA [5]. 
2. GABA and Other Neurotransmitters 
There are many neurochemicals such as GABA, Glutamate, serotonin, dopamine, and acetylcholine present be-
fore the neuronal differentiation does occur in the fetal brain and play modulatory role in neuronal differentia-
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tion, proliferation and migration (Table 1). The developmental abnormalities in autism may be related to the 
expression of numerous genes that normally silenced during the post natal development [6]. Many genes remain 
switched on which stunned axodendrtic development but still GABA seems to be the most distinguished candi-
date for autism. At the early stage of development neuronal GABA receptors function as excitatory due to the 
high Cl− concentration inside the cell, and resultant efflux of Cl−. Dysregulation of monoamines neurotransmit-
ters such as serotonin can modify neural activity widely across the forebrain, and thereby affect the progressive 
refinement and emergent efficiencies of all forebrain-processing systems. GABA and its relationship with other 
neurotransmitters and neuromodulators may involve in triggering autism and autistic behaviors. GABA related 
changes in neurotransmitters, branched chain amino acids, cell adhesion molecules and neurotropic factors ef-
fect on the developing fetus and newborn. 
3. Neurotransmitters Interaction with GABA and Development of Autism 
During the early stage of development GABAergic excitation cooperates with N-methyl-D-aspartate receptors 
(NMDARs) to drive spontaneous synchronous activity (SSA) by removal of Mg+ blockade of NMDA and influx 
of Ca++ [7]. SSA is fundamentally important for developing neuronal network and suppressed GABAergic inhi-
bition involves in pathophysiology of autism through this pathway. Similarly, reduced availability of glutamic 
acid decarboxylase (GAD), enzyme responsible for the synthesis of GABA can lead to delayed myelination and 
synaptic maturation, learning and memory processes. While decrease numbers of GABA interneuron per units 
of cortical minicolumns and low levels of GABA concentration at the synapse shown to be involved in autism. 
GABAergic neurons are sensitive to glutamate analog (NMDA) resulting in the loss of inhibitory control which 
in turn damage the large pyramidal and multipolar neurons and may contribute to the pathology of autism [8]. 
Significant loss of Purkinje cells and pyramidal neurons in the frontal cortex, and in limbic system were ob-
served in autism. GABAergic dysfunction may either result in direct alterations in GABA systems or in neuro-
modulation of GABAergic neurons via several neuromodulators that are reported to be involved in such changes, 
potentially with synergistic effects (Table 2). Acetylcholine is one of them cholinergic dysfunction may have an 
indirect contribution in the development of autistic symptoms via its influence on GABAergic neurons, a corre-
late of prior GABAergic dysfunction, or work as a direct contributor through its influence on synaptic develop-
ment [9]. The α7 nicotinic acetylcholine receptor which has been reported to be found on the surface of GABA 
inhibitory neurons promote, GABA release and can restore diminished inhibitory tone. While α4 β2 nicotinic 
acetylcholine receptor which has regulatory effect on GABAergic neurons have shown to be decreased in the 
cerebral neocortex and in the cerebellum of autistic patients. The serotonergic system is involved in the regulation 
 
Table 1. Modulatory action of Serotonin receptors on GABAergic receptors neurotransmission in various brain regions.      
Table Serotonin modulatory effect on GABA 
Serotonin/receptors GABA/ receptors Mechanism involved Location in brain regions References 
5HT GABAB 
5-HT inhibitsGABAB mediated IPSCs acting  
both pre and post synaptically CA3 pyramidal neurons [17] 
5HT GABAB 
5-HT and GABAB receptors increase and  
decrease Ttype Ca2+ 
Interneurons from stratum  
lacunosum-moleculare [18] 
5-HT3 GABA Stimulates GABA release 
Basolateral amygdala  
(from interneurons) [19] [20] 
5-HT2 and 5-HT4 GABAA 
Modulate post synaptically GABAA  
mediated effect 
Pyramidal neurons from  
prefrontal cortex [21] 
5-HT2 GABAA 
Promotes Phosphorylation of GABAA receptors by  
activating on protein kinase C (PKC) which reduces  
GABAA mediated Cl− currents. 
Pyramidal neurons from  
prefrontal cortex [21] 
5-HT4 GABAA 
Modulates GABAA mediated current depending on  
protein kinase A (PKA)activation level 
Pyramidal neurons from  
prefrontal cortex [21] 
5HT GABA GABA release, strengthen local GABAergic inhibition  and modulate thalamic processing of sensory signals 
Dendrites of thalamic  
interneurons [22] 
5-HT2 GABAA 
Enhances GABAA induced Cl− current acting 
through a protein kinase dependent pathway Spinal dorsal horn, [23]-[25] 
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Table 2. Represent the role of neurotransmitters in the development of Autism and other Neurological disorders.            
Pathological maturation of neurotransmitter systems in the developmental of Autism 
Brain regions/  
migration  Synaptic integration  Network activity/plasticity  




Blockade of  
GABAergic activities Cortical excitatory inputs Autism 
Cortical region (5HT2A) receptor activity  on GABAergic interneurons Glutamate signaling 
Developmental disorder  
such as Autism 
Pyramidal and  
multipolar neurons 
GABAergic neurons are sensitive  
to glutamate analog (NMDA)  
Damage the large pyramidal  
and multipolar neurons Autism 
GABA 
Cortex 
Postnatal  in cortical 
GABAergic neurons Excitation and Noise in Cortex Autism 
Acetylcholine 
Cerebral neocortex 
α4 β2 nicotinic acetylcholine  
receptor on GABAergic neurons GABAergic activity Autism 
Cerebellum α4, α2 nicotinic  acetylcholine receptor GABAergic activity 
Reported in  
autistic patients 
Hippocampus Prenatal stress Level of acetylcholine Developmental disorders  including Autism 
Cerebral cortex α4 β2 acetylcholine receptor Interneuron GABAergic  neurotransmission Autism 
Serotonin 
Cortex 
Destruction of 5HT afferents by  
using Pchlorophenylalanine at  
a critical period(E12 to E17) 
Abnormal distribution of 
GABAergic interneurons Developmental disorders 
Prefrontal cortex 5HT2A receptor agonists 
Reduced GABAA currents by  
activation of protein kinase (PKC) 
which decreases GABAA mediated  
Cl− currents 
Autism 
Prefrontal cortex  
pyramidal neurons 5HT4 receptor 
±GABAA mediated current depending  
on Protein Kinase (PKA) levels 
Autistic Spectrum Disorder 
Dopamine 
cerebral cortex 
Pysiological changes in  
dopamine D1 and D2 receptors 
Cause alteration  
in GABA neuron migration  
at the embryonic stage 
Autism 
Telencephalic  
regions DAergic innervation significant GABA dysfunction 
Neuronal disorders including  
schizophrenia  
 
of emotional processes and cognitive behaviors. There are several 5HT receptors; most of them belongs to G 
protein family, while 5-HT3 receptor is a ligand-gated ion channel receptor and expressed on GABAergic neu-
rons in neocortex and suggested to be involved in controlling excitation and inhibition of cortical columns. Ac-
tivation of 5HT3 induces a transient enhancement of inhibitory postsynaptic currents (IPSCs) in neocortex and 
hippocampus [10]. 5-HT2A receptor agonists can reduce GABAA currents by activating protein kinase C (PKC) 
in most of prefrontal cortex pyramidal neurons and reduce GABAA mediated Cl− currents. The overlapping 
between expression of 5HT2A and GABAA receptors suggested that they may be co localized at some synapses 
of pyramidal neurons in the prefrontal cortex (Figure 1, [28]). 
Similarly, 5HT4R are also located on pyramidal neurons of prefrontal cortex and has dual effect on GABAA 
mediated currents, i.e. can either enhance or depress depending on protein kinase A (PKA) levels. Dopamine 
(DA), a catecholamine synthesized from tyrosine by tyrosine hydroxylase is present in mesolimbic, nigrostrial, 
and mesocortical systems and are involved in controlling variety of functions such as cognition, motor function 
and reward mechanism. Ventral tegmental area (VTA) a group of neurons that are found on the floor of mid-
brain can mediate activation of mesofrontal DA system which effect on various neurotransmitters including 5HT, 
NE, acetylcholine, GABA and opioid peptides [11]. Any alteration in dopamine D1 and D2 receptors can cause 
modification in GABA neuronal migration to the cerebral cortex at the embryonic stage. Hence dopamine dis-
parity during development can have an impact on GABA neurons expansion in multiple brain regions [12]. 




Figure 1. Diagram represent GABAA receptor regulation by 
signal transduction cascade through 5-HT2 in prefrontal cortex. 
5-HT2R stimulates Phospholipase C results in the release of IP3 
and DAG. Whereas PKC and RACK1 leads to phosphorylation 
of GABAAR and hence reducing GABA currents.             
 
Prenatal intake of cocaine or DA receptor agonists can disrupt tangential migration of GABAergic neurons be-
cause GABAergic neurons in forebrain regions receive dopaminergic innervation when migrate to cortex during 
embryonic period. It has been reported that significant GABA dysfunction in multiple telencephalic regions is 
associated with multiple neuronal disorders including autism. Similarly, brain drive neurotropic factor (BDNF) 
attenuates inhibitory transmission and decrease the efficacy of inhibitory transmission by acute postsynaptic 
down regulation of Cl− transport. Similarly, cell adhesion molecules neurexins and neuroligins are trans-synaptic 
cell adhesion pair and are involved in synaptic functions. The interaction between neurexins and neuroligins are 
thought to trigger postsynaptic differentiation [13] and the balance between inhibitory GABA and excitatory 
glutamate inputs [14]. Other studies on mice carrying neuroligin3 (Nlgn3) gene mutation shows behavioral 
phenotypes related to ASD suggesting that the R451C mutation switches Nlgn3 synaptic specificity from gluta-
mergic to GABAergic [15]. The branched chain amino acid (BCAA) is the combination of three essential amino 
acid leucine, isoleucine and valine and metabolism of BCAA is different from metabolic pathway of other ami-
no acids. Mutation of Branched Chain alpha-Keto acid Dehydrogenase Kinase (BCKDK) gene which inactivates 
BCKD-kinase complex prevents the breakdown of BCAA. This BCKD-kinase mutation was reported in con-
sanguineous families with autism, and total loss of kinase activity was present in homozygous participants [16]. 
Imbalanced excitation or inhibition of neurochemicals may be responsible for cytotoxicity in the developing 
brain and resultant behavioral deficits. GABA seems to be the most influential neurotransmitter during fetal de-
velopment and any change in GABAergic migration and neurotransmission by monoamine neurotransmitters 
such as serotonin can alter GABAergic neuronal activity, migration and distribution. Suppressed GABAergic 
activity during critical period of development might result in the developmental disorders like autism and a pe-
ripheral marker such as platelet is essential for timely diagnosis of ASD and treatment effects. 
GABAergic activities suggested to be crucial in pathophysiology of depressive behaviors and decreased GABA 
activity which would probably be a feature of a subset of mood disorder patients, possibly representing a genetic 
susceptibility to develop unipolar or bipolar disorder. However, neurotransmission of GABA appears to be in-
volved in the mechanism of action of antidepressant and mood stabilizers. GABAergic pathways that appear to 
modulate monoaminergic and serotonergic systems, it is speculate that low basal GABA level can cause reduced 
levels of monoaminergic and serotonergic transmission and deficit in GABAergic neurotransmission in mood 
disorders would be complementary to the well-established alteration in monoaminergic and serotonergic systems 
which would suggest that an alteration in balance neurotransmission of these neurotransmitters (GABA, Serotonin) 
in depressive behaviors. 
Depression can occur with autism however, clinical studies support that it is most common psychiatric illness 
seen in autism. In some cases depression in autism could occur by chance, or it could result from combination of 
genetic or environmental factors or both. The diagnostic criteria for people with depression in autism represent 
wide range of symptoms such as social withdrawal and appetite and sleep disturbance, and these are also core 
symptoms of depression. Depression can be reliably diagnosed in high functioning persons using same criteria 
as for the general population. Impairments in verbal and nonverbal skills can mask the symptoms of depression 
whereas, symptoms associated with autism such as obsession and self-injury may be increased during an episode 
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of depression in autistic individuals [26]-[28]. 
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